Cognition Therapeutics INC Form 4 insider transactions

Director Jack A. Khattar acquired 8,500 shares and options in Cognition Therapeutics on June 7, 2024.

Director Ellen Richstone acquired 8,500 shares of common stock and stock options in Cognition Therapeutics, according to a recent SEC filing.

Director Brett P. Monia acquired 8,500 shares of common stock and options to purchase 8,500 shares of Cognition Therapeutics stock on June 7, 2024.

John Brendan Doyle, CFO of Cognition Therapeutics, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.

CEO Lisa Ricciardi purchased 5,700 shares of Cognition Therapeutics (CGTX) at $1.75 per share on March 14, 2024, increasing her direct holdings to 291,345 shares.